Therapeutic use of Aldara in chronic myeloid leukemia.

about

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?The immunologic aspects of poxvirus oncolytic therapy

P2860

Q34704572-8F67A196-22CF-44C6-8057-9E8A3946DF23 Q36115128-0C870B2A-6A19-4F60-AE2A-64EEF21742B4

P2860

Therapeutic use of Aldara in chronic myeloid leukemia.

Item

http://www.wikidata.org/entity/Q36718548

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Therapeutic use of Aldara in chronic myeloid leukemia.

@ast

Therapeutic use of Aldara in chronic myeloid leukemia.

@en

type

Item

label

Therapeutic use of Aldara in chronic myeloid leukemia.

@ast

Therapeutic use of Aldara in chronic myeloid leukemia.

@en

prefLabel

Therapeutic use of Aldara in chronic myeloid leukemia.

@ast

Therapeutic use of Aldara in chronic myeloid leukemia.

@en

P1476

Therapeutic use of Aldara in chronic myeloid leukemia.

@en

P2093

Annette M Marleau

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Lipton

http://www.w3.org/2001/XMLSchema#string

Neil H Riordan

http://www.w3.org/2001/XMLSchema#string

Thomas E Ichim

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo.

Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine.

Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.

P2888

1479-5876-5-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/1479-5876-5-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2007-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6550237

http://www.w3.org/2001/XMLSchema#string

P6179

1000852803

http://www.w3.org/2001/XMLSchema#string

P698

17254347

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

1790884

http://www.w3.org/2001/XMLSchema#string

Therapeutic use of Aldara in chronic myeloid leukemia.

about

P2860

P2860

Therapeutic use of Aldara in chronic myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P478

P5008

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P478

P5008

P577

P5875

P6179

P698

P921

P932